Yili Chuanning Biotechnology Co.,Ltd. (SHE: 301301)
China
· Delayed Price · Currency is CNY 14.22
+0.08 (0.57%)
Nov 15, 2024, 9:34 AM CST
Yili Chuanning Biotechnology Co.,Ltd. Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Operating Revenue | 5,390 | 4,515 | 3,574 | 3,055 | 3,366 | 2,849 | Upgrade
|
| Other Revenue | 308.58 | 308.58 | 246.72 | 177.08 | 283.45 | 294.48 | Upgrade
|
| Revenue | 5,698 | 4,823 | 3,821 | 3,232 | 3,649 | 3,143 | Upgrade
|
| Revenue Growth (YoY) | 27.69% | 26.24% | 18.21% | -11.44% | 16.10% | -6.15% | Upgrade
|
| Cost of Revenue | 3,694 | 3,343 | 2,890 | 2,637 | 3,007 | 2,616 | Upgrade
|
| Gross Profit | 2,005 | 1,480 | 930.89 | 595.07 | 641.97 | 527.88 | Upgrade
|
| Selling, General & Admin | 184.47 | 165.7 | 155.54 | 130.22 | 122.59 | 132.25 | Upgrade
|
| Research & Development | 60.27 | 55.26 | 35.38 | 32.95 | 25.05 | 18.18 | Upgrade
|
| Other Operating Expenses | 81.56 | 66.52 | 54.94 | 36.7 | 36.14 | 28.78 | Upgrade
|
| Operating Expenses | 330.65 | 293.98 | 260.12 | 198.27 | 184.53 | 224.47 | Upgrade
|
| Operating Income | 1,674 | 1,186 | 670.77 | 396.8 | 457.44 | 303.42 | Upgrade
|
| Interest Expense | -58.9 | -87.78 | -142.34 | -176.88 | -173.66 | -189.6 | Upgrade
|
| Interest & Investment Income | 9.25 | 16.18 | 5.21 | 9.2 | 3.11 | 0.65 | Upgrade
|
| Currency Exchange Gain (Loss) | 12.18 | 12.18 | 14.71 | -5.37 | -8.35 | 3.65 | Upgrade
|
| Other Non Operating Income (Expenses) | -30.32 | -1.41 | -0.64 | -0.95 | -1.48 | -3.51 | Upgrade
|
| EBT Excluding Unusual Items | 1,606 | 1,125 | 547.7 | 222.8 | 277.07 | 114.61 | Upgrade
|
| Gain (Loss) on Sale of Investments | -7.85 | -14.73 | -8.96 | 0.55 | 0.42 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 1.34 | - | 0.26 | - | - | Upgrade
|
| Asset Writedown | 23.15 | - | - | -5.79 | -1.41 | -4.35 | Upgrade
|
| Other Unusual Items | 5.64 | 5.64 | -51.11 | -83.74 | - | - | Upgrade
|
| Pretax Income | 1,627 | 1,118 | 487.63 | 134.08 | 276.07 | 110.26 | Upgrade
|
| Income Tax Expense | 250.67 | 177.15 | 76.11 | 22.73 | 47.07 | 20.04 | Upgrade
|
| Earnings From Continuing Operations | 1,376 | 940.56 | 411.52 | 111.35 | 229 | 90.22 | Upgrade
|
| Minority Interest in Earnings | -0.04 | -0 | 0 | -0 | -0 | 1.17 | Upgrade
|
| Net Income | 1,376 | 940.56 | 411.52 | 111.35 | 229 | 91.39 | Upgrade
|
| Net Income to Common | 1,376 | 940.56 | 411.52 | 111.35 | 229 | 91.39 | Upgrade
|
| Net Income Growth | 91.32% | 128.56% | 269.58% | -51.38% | 150.58% | -76.56% | Upgrade
|
| Shares Outstanding (Basic) | 2,265 | 2,239 | 1,960 | 1,856 | 2,000 | - | Upgrade
|
| Shares Outstanding (Diluted) | 2,265 | 2,239 | 1,960 | 1,856 | 2,000 | - | Upgrade
|
| Shares Change (YoY) | 5.39% | 14.28% | 5.60% | -7.21% | - | - | Upgrade
|
| EPS (Basic) | 0.61 | 0.42 | 0.21 | 0.06 | 0.11 | - | Upgrade
|
| EPS (Diluted) | 0.61 | 0.42 | 0.21 | 0.06 | 0.11 | - | Upgrade
|
| EPS Growth | 81.54% | 100.00% | 250.00% | -45.45% | - | - | Upgrade
|
| Free Cash Flow | 843.99 | 947.26 | 644.44 | 750.94 | 560.59 | -212.19 | Upgrade
|
| Free Cash Flow Per Share | 0.37 | 0.42 | 0.33 | 0.40 | 0.28 | - | Upgrade
|
| Dividend Per Share | 0.225 | 0.225 | 0.093 | - | - | - | Upgrade
|
| Dividend Growth | 141.46% | 141.46% | - | - | - | - | Upgrade
|
| Gross Margin | 35.18% | 30.69% | 24.36% | 18.41% | 17.59% | 16.79% | Upgrade
|
| Operating Margin | 29.38% | 24.60% | 17.56% | 12.28% | 12.53% | 9.65% | Upgrade
|
| Profit Margin | 24.15% | 19.50% | 10.77% | 3.45% | 6.28% | 2.91% | Upgrade
|
| Free Cash Flow Margin | 14.81% | 19.64% | 16.87% | 23.23% | 15.36% | -6.75% | Upgrade
|
| EBITDA | 2,216 | 1,730 | 1,217 | 919.79 | 948.73 | 759.38 | Upgrade
|
| EBITDA Margin | 38.88% | 35.86% | 31.85% | 28.46% | 26.00% | 24.16% | Upgrade
|
| D&A For EBITDA | 541.66 | 543.55 | 546.07 | 522.99 | 491.29 | 455.96 | Upgrade
|
| EBIT | 1,674 | 1,186 | 670.77 | 396.8 | 457.44 | 303.42 | Upgrade
|
| EBIT Margin | 29.38% | 24.59% | 17.56% | 12.28% | 12.53% | 9.65% | Upgrade
|
| Effective Tax Rate | 15.41% | 15.85% | 15.61% | 16.96% | 17.05% | 18.18% | Upgrade
|
| Revenue as Reported | 5,698 | 4,823 | 3,821 | 3,232 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.